Journal of the Korean Applied Science and Technology (한국응용과학기술학회지)

The Korean Society of Applied Science and Technology (한국응용과학기술학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Seomaeyakssuk (Artemisia argyi H.) Extracts on Anti-pruritic Activities

항가려움증 활성에 섬애약쑥(Artemisia argyi H.) 추출물이 미치는 영향

  • Lee, Hea-Jin (Department of Beauty Healthcare, Daejeon University) ;
  • Lim, Hyun-Ji (Department of Beauty Medical, Daejeon University) ;
  • Lim, Mi-Hye (Department of Beauty Healthcare, Daejeon University)
  • 이해진 (대전대학교 뷰티건강관리학과) ;
  • 임현지 (대전대학교 미용의학과) ;
  • 임미혜 (대전대학교 뷰티건강관리학과)
  • Received : 2021.10.03
  • Accepted : 2021.10.28
  • Published : 2021.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of this study was to investigate the anti-pruritic activities such as cell viability and pruritus-related factor using seomaeyakssuk (Artemisia argyi H.; Seomaeyakssuk) extract on MC/9 (mouse mast cell line). Seomaeyakssuk was extracted from hot distilled water. Cell viability was assessed using MTT assay on MC/9 cells. Anti-pruritic activities were measured through changes in the levels of transcription factor (IL4 and IL31) on MC/9 cells. In addition, the expression of linked proteins and histamine was measured. The results confirmed that significant cytotoxicity does not appear in the concentration range of 25, 50, and 100 ㎍/㎖. The levels of IL4 was reduced to 12% (25 ㎍/㎖), 26% (50 ㎍/㎖) and 61% (100 ㎍/㎖). Also, level of IL31 was decreased 33% (50 ㎍/㎖) and 36% (100 ㎍/㎖). In the case of proteins levels decreased significantly IL-4 34%/69% and IL-31 36%/37% at 50 ㎍/㎖ and 100 ㎍/㎖. Histamine decreased by 22, 58% and 61%, respectively, at concentrations of 25, 50, and 100 ㎍/㎖. This results shows possibility of ADD as raw material in anti-pruritic products.

본 연구는 섬애약쑥(Artemisia argyi H.)의 항가려움증 활성 가능성을 확인하기 위한 연구로써 가려움증 관련인자 등을 측정하였다. 섬애약쑥은 열수로 추출(Artemisia argyi H. distilled water extract 이하, AAD)하여 MTT assay로 세포독성을 측정하였고 항 가려움증 활성을 확인하기 위하여 IL-4와 IL-31 관련 전사인자 발현 및 단백질 생성을 측정하였으며, 히스타민의 발현을 측정하였다. 그 결과 25, 50, 100 ㎍/㎖의 농도에서는 유의한 세포독성이 나타나지 않는 것을 확인하였다. 가려움증 연관 유전인자인 IL4의 경우 25 ㎍/㎖의 농도에서 약 12%, 50 ㎍/㎖의 농도에서 약 26%, 100 ㎍/㎖의 농도에서 약 61%로 유의하게 감소하였으며, IL31의 경우 50 ㎍/㎖의 농도에서 약 33%, 100 ㎍/㎖의 농도에서 약 33%로 유의하게 감소하였다. 연관된 단백질 측정의 경우 각각 50 ㎍/㎖와 100 ㎍/㎖의 농도에서 IL-4는 약 34% 및 약 69%, IL-31은 약 36% 및 약 37% 유의하게 감소하였다. 이 결과는 ADD가 항가려움증을 위한 소재로써 가능성을 보여 소재 개발을 위한 기초자료로 제공될 수 있을 것으로 사료된다.

Keywords

Acknowledgement

이 논문은 2020년 대전대학교 교내연구비 지원에 의해 연구되었습니다.

References

  1. G. J. Ha, C. H. Jeong, H. R. Jeong, H. J. Heo, G. M. Shon, C. W. Rho, N. K. Kim, "Antioxidant Activities from the Different Parts of Artemisia Argyi H. using an in Vitro System", The Journal of Agricultural Science, Vol.45, No.1 pp. 109-117, (2011).
  2. T. H. Rho, G. S. Seo, "Growth Characteristics and Chemical Components in Local Collections of Artemisia Sp.", Korean Journal of Medicinal Crop Science, Vol.1, No.2 pp. 171-177, (1993).
  3. I. S. Carvalho, T. Cavaco, M. Brodelius, "Phenolic composition and antioxidant capacity of six artemisia species", Industrial Crops and Products, Vol.33, pp. 382-388, (2011). https://doi.org/10.1016/j.indcrop.2010.11.005
  4. M. H. Park, M. J. Kim, W. I. Cho, P. S. Chang, J. H. Lee, "Effects of treatments on the distribution of volatiles in Artemisia princeps Pampan", Korean Journal of Food Science and Technology, Vol.41, pp. 587-591, (2009).
  5. H. J. Lee, Y. I. Hwang, E. J. Park, S. U. Choi, "Antihepatotoxic and antigenotoxic effects of herb tea composed of Chrysanthemum morifolium Ramat", Journal of the Korean Society of Food Science and Nutrition, Vol.40, pp. 78-83, (2011) https://doi.org/10.3746/JKFN.2011.40.1.078
  6. S. Ntutela, P. Smiyh, L. Matika, J. Mukinda, H. Arendse, N. Allie, D. M. Estes, M. Mabusela, P. Folb, M. Steyn, Q. Johnson, W. R. Folk, J. Syce, M. Jacobsb, "Efficacy of Artemisia afra phytotherapy in experimental tuberculosis", Tuberculosis (Edinb), Vol.89, pp. S33-S40, (2009) https://doi.org/10.1016/S1472-9792(09)70009-5
  7. R. J. Kim, M. J. Kang, C. R. Hwang, W. J. Jung, J. H. Shin, "Antioxidant and cancer cell growth inhibition activity of five different varieties of Artemisia cultivars in Korea", Journal of Life Science, Vol.22, pp. 844-851, (2012) https://doi.org/10.5352/JLS.2012.22.6.844
  8. A. H. Al-Mustafa, O. Y. Al-Thunib, "Antioxidant activity of some Jordanian medicinal plants used traditionally for treatment of diabetes", Pakistan Journal of Biological Sciences, Vol.11, pp. 351-358, (2008) https://doi.org/10.3923/pjbs.2008.351.358
  9. C. K. Lee, J. J. Seo, "Antimicrobial activity of the aerial part of Artemisia capillaries extracts on the food-borne pathogens", Journal of the Korean Society of Food Science and Nutrition, Vol.32, pp. 1227-1232, (2003) https://doi.org/10.3746/JKFN.2003.32.8.1227
  10. J. Y. Shin, J. R. Kang, J. H. Shin, W. T. Seo, H. U. Byun, J. S. Choi, M. J. Kang, "Effects of Seomaeyakssuk (Artemisia argyi H.) Vinegar on Lipid Metabolism in Rats Fed a High-Fat and High-Cholesterol Diet", Journal of the Korean Society of Food Science and Nutrition, Vol.46, No7 pp. 779-789, (2017)
  11. D. G. Kim, J. R. Kang, J. H. Shin, M. J. Kang, "Biological Activities of Various Solvent Extracts of Seomaeyakssuk (Artemisia argyi H.)", Journal of Life Science, Vol.29, No.11 pp. 1241-1250, (2019)
  12. C. R. Hwang, W. T. Seo, W. Y. Bae, M. J. Kang, J. H. Shin, "Physicochemical Characteristics and Biological Activities of Artemisia Argyi H.", Journal of Life Science, Vol.24, No.4 pp. 377-385, (2014) https://doi.org/10.5352/JLS.2014.24.4.377
  13. H. Y. Han, H. J. Kim, S. H. Jeong, J. Y. Kim, S. H. Jeong, G. C. Kim, D. S. Hwang, U. K. Kim, M. H. Ryu, "The Flavonoid Jaceosidin from Artemisia Princeps Induces Apoptotic Cell Death and Inhibits the Akt Pathway in Oral Cancer Cells", Evidence-Based Complementary and Alternative Medicine, Vol.2018, pp. 1-9, (2018).
  14. H. M. Lee, D. I. Jang, J. M. Jeon, C. M. Cho, S. I. Choi, S. J. Han, E. J. Oh, J. H. Nam, C. H. Park, Y. S. Shin, S. P. Yun, S. Y. Yang, L. J. Kang, "Seomae Mugwort and Jaceosidin Attenuate Osteoarthritic Cartilage Damage by Blocking IκB Degradation in Mice", Journal of Cellular and Molecular Medicine, Vol.24, No.14 pp. 8126-8137, (2020). https://doi.org/10.1111/jcmm.15471
  15. V. Moscatelli, O. Hnatyszyn, C. Acevedo, J. Megias, M. J. Alcaraz, G. Ferraro, "Flavonoids from Artemisia Copa with Anti-Inflammatory Activity", Planta Medica, Vol.72, No.1 pp. 72-74, (2006). https://doi.org/10.1055/s-2005-873177
  16. M. J. Kim, J. M. Han, Y. Y. Jin, N. I. Baek, M. H. Bang, H. G. Chung, M. S. Choi, K. T. Lee, D. E. Sok, T. S. Jeong, "In Vitro Antioxidant and AntiInflammatory Activities of Jaceosidin from Artemisia Princeps Pampanini Cv. Sajabal", Archives of Pharmacal Research, Vol.31, No.4 pp. 429-437, (2008). https://doi.org/10.1007/s12272-001-1175-8
  17. J. Y. Kim, M. S. Lee, J. M. Baek, J. T. Park, B. S. Youn, J. M. Oh, "Massive Elimination of Multinucleated Osteoclasts by Eupatilin is due to Dual Inhibition of Transcription and Cytoskeletal Rearrangement", Bone Reports, Vol.3, pp. 83-94, (2015). https://doi.org/10.1016/j.bonr.2015.10.003
  18. J. E. Son, E. Lee, S. G. Seo, J. Lee, J. E. Kim, J. Kim, K. W. Lee, H. J. Lee, "Eupatilin, a Major Flavonoid of Artemisia, Attenuates Aortic Smooth Muscle Cell Proliferation and Migration by Inhibiting PI3K, MKK3/6, and MKK4 Activities", Planta Medica, Vol.79, No.12 pp. 1009-1016, (2013). https://doi.org/10.1055/s-0033-1350621
  19. X. Fei, J. Wang, C. Chen, B. Ding, X. Fu, W. Chen, C. Wang, R. Xu, "Eupatilin Inhibits Glioma Proliferation, Migration, and Invasion by Arresting Cell Cycle at G1/S Phase and Disrupting the Cytoskeletal Structure", Cancer Management and Research, Vol.11, pp. 4781-4796, (2019). https://doi.org/10.2147/CMAR.S207257
  20. J. S. Kim, S. G. Lee, K. Min, T. K. Kwon, H. Kim, J. Nam, "Eupatilin Inhibits Adipogenesis through Suppression of PPARγ Activity in 3T3-L1 Cells", Biomedicine & Pharmacotherapy, Vol.103, pp. 135-139, (2018). https://doi.org/10.1016/j.biopha.2018.03.073
  21. J. K. Kim, E. Shin, H. Lim, S. J. Choi, C. R. Kim, S. H. Suh, C. Kim, G. G. Park, C. Park, H. K. Kim, J. H. Choi, S. Song, D. Shin, "Characterization of Nutritional Composition, Antioxidative Capacity, and Sensory Attributes of Seomae Mugwort, a Native Korean Variety of Artemisia Argyi H. Lev. & Vaniot", Journal of Analytical Methods in Chemistry, Vol. Special, pp. 1-9, (2015).
  22. S. M. Kim, S. J. Lee, V. G. S. Venu, S. E. Ha, P. Vetrivel, K. T. Desta, J. Y. Choi, W. S. Lee, S. C. Shin, G. Kim, "Polyphenol Mixture of a Native Korean Variety of Artemisia Argyi H. (Seomae Mugwort) and its Anti-inflammatory Effects", International Journal of Molecular Medicine, Vol.44, No.5 pp. 1741-1752, (2019).
  23. H. J. Lee, M. H. Lim, "Whitening Activities of Extracts of Seomaeyakssuk (Artemisia Argyi H.)", Journal of the Korean Applied Science and Technology, Vol.37, No.2 pp. 241-249, (2020).
  24. S. Stander, M. Steinhoff, M. Schmelz, E. Weisshaar, D. Metze, T. Luger, "Neurophysiology of Pruritus: Cutaneous Elicitation of Itch", Archives of Dermatological Research, Vol.139, No.11 pp. 1463-1470, (2003).
  25. D. Agnello, C. S. R. Lankford, J. Bream, A. Morinobu, M. Gadina, J. J. O'Shea, D. M. Frucht, "Cytokines and Transcription Factors that Regulate T Helper Cell Differentiation: New Players and New Insights", Journal of Clinical Immunology, Vol.23, No.3 pp. 147-161, (2003). https://doi.org/10.1023/A:1023381027062
  26. Van der Heijden, F L, Joost van Neerven, R J, M. Van Katwijk, J. D. Bos, M. L. Kapsenberg, "Serum-IgE-Facilitated Allergen Presentation in Atopic Disease", The Journal of Immunology, Vol.150, No.8 pp. 3643-3650, (1993).
  27. M. K. Church, F. Levi-Schaffer, "Allergy", Allergy, Vol.99, No.2 pp. 155-160, (1978).
  28. S. Kim, H. Kim, H. S. Yang, E. Kim, I. Huh, J. Yang, "IL-31 Serum Protein and Tissue mRNA Levels in Patients with Atopic Dermatitis", Annals of Dermatology., Vol.23, No.4 pp. 468-473, (2011). https://doi.org/10.5021/ad.2011.23.4.468
  29. T. Zheng, M. H. Oh, S. Y. Oh, J. T. Schroeder, A. B. Glick, Z. Zhu, "Transgenic Expression of Interleukin-13 in the Skin Induces a Pruritic Dermatitis and Skin Remodeling", Journal of Investigative Dermatology, Vol.129, No.3 pp. 742-751, (2009). https://doi.org/10.1038/jid.2008.295
  30. P. M. Brunner, E. Guttman-Yassky, D. Y. M. Leung, "The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies:, Journal of Allergy and Clinical Immunology, Vol.139, pp. 65-76, (2017).
  31. L. A. Beck, D. Thaci, J. D. Hamilton, N. M. Graham, T. Bieber, R. Rocklin, J. E. Ming, H. Ren, R. Kao, E. Simpson, M. Ardeleanu, S. P. Weinstein, G. Pirozzi, E. Guttman-Yassky, M. Suarez-Farinas, M. D. Hager, N. Stahl, G. D. Yancopoulos, A. R. Radin, "Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis", The New England Journal of Medicine, Vol.371, No.2 pp. 130-139, (2014). https://doi.org/10.1056/nejmoa1314768
  32. Y. H. Jeon, J. H. Kim, "Update on Management of Pediatric Atopic Dermatitis", Allergy, Asthma & Respiratory Disease, Vol.9, No.2 pp. 59-68, (2021). https://doi.org/10.4168/aard.2021.9.2.59
  33. R. Heise, M. M. Neis, Y. Marquardt, S. Joussen, P. C. Heinrich, H. F. Merk, H. M. Hermanns, J. M. Baron, "IL-31 Receptor Alpha Expression in Epidermal Keratinocytes is Modulated by Cell Differentiation and Interferon Gamma", Journal of Investigative Dermatology, Vol.129, No.1 pp. 240-243, (2009). https://doi.org/10.1038/jid.2008.183
  34. E. Sonkoly, A. Muller, A. I. Lauerma, A. Pivarcsi, H. Soto, L. Kemeny, H. Alenius, M. Dieu-Nosjean, S. Meller, J. Rieker, M. Steinhoff, T. K. Hoffmann, T. Ruzicka, A. Zlotnik, B. Homey, "IL-31: A New Link between T Cells and Pruritus in Atopic Skin Inflammation", Journal of Allergy and Clinical Immunology, Vol.117, No.2 pp. 411-417, (2006). https://doi.org/10.1016/j.jaci.2005.10.033
  35. U. Raap, K. Wichmann, M. Bruder, S. Stander, B. Wedi, A. Kapp, T. Werfel, "Correlation of IL-31 Serum Levels with Severity of Atopic Dermatitis", Journal of Allergy and Clinical Immunology, Vol.122, No.2 pp. 421-423, (2008). https://doi.org/10.1016/j.jaci.2008.05.047
  36. S. Dillon, C. Sprecher, A. Hammond, J. Bilsborough, M. Rosenfeld-Franklin, S. Presnell, H. Haugen, M. Maurer, B. Harder, J. Johnston, S. Bort, S. Mudri, J. Kuijper, T. Bukowski, P. Shea, D. Dong, M. Dasovich, F. Grant, L. Lockwood, J. Gross, "Erratum: Interleukin 31, a Cytokine Produced by Activated T Cells, Induces Dermatitis in Mice", Nature Immunology, Vol.5, No.7 pp. 752-60, (2004). https://doi.org/10.1038/ni1084
  37. M. K. Church, M. Maurer, "H1 -Antihistamines and Itch in Atopic Dermatitis", Experimental Dermatology, Vol.24, No.5 pp. 332-333, (2015). https://doi.org/10.1111/exd.12626
  38. M. W. Greaves, P. D. Wall, "Pathophysiology of Itching", The Lancet, Vol.348, No.9032 pp. 938-940, (1996). https://doi.org/10.1016/S0140-6736(96)04328-0
  39. S. Stander, U. Raap, E. Weisshaar, M. Schmelz, T. Mettang, H. Handwerker, T. A. Luger, "Pathogenesis of Pruritus", Journal der Deutschen Dermatologischen Gesellschaft, Vol.9, No.6 pp. 456-463, (2011).
  40. J. D. Kim, C. Y. Han, G. Y. Seo, K. S. Kim, Y. B. Kim, "A Review of the Latest Discussions on the Mechanism of Itching - A Study on Recent Research Trend and the Relationship between Gastrointestinal Tract and Itching", Journal of Korean Medicine Ophthalmology & Otolaryngology & Dermatology, Vol.34, No.3 pp. 55-69, (2021). https://doi.org/10.6114/JKOOD.2021.34.3.055